Clinical Trial Update: Nerivio Device for Treatment of New Daily Headache Persistence (NDHP) [NA]

View source ↗

Summary

A clinical trial evaluating the Nerivio device for New Daily Persistent Headache (NDPH) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• New Daily Persistent Headache

Drugs mentioned

• Nerivio

Snippet

Sponsor: Children's National Research Institute | Conditions: New Daily Persistent Headache (NDPH) | NA | Status: WITHDRAWN